Clairvoyant Therapeutics is a Canadian biotech company focused on psychedelic therapy drug development for addiction. Clairvoyant is at the forefront of a growing psychedelic therapy industry and operates under the principles of open science. Our team has a successful track record of designing and operating clinical trials and bringing new drugs to market.
Location: Canada, British Columbia, Vancouver
Investors 2
| Date | Name | Website |
| - | Iter Inves... | iterinvest... |
| - | Ambria Cap... | ambriacap.... |
Mentions in press and media 1
| Date | Title | Description |
| 03.11.2022 | First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder | VANCOUVER, BC / ACCESSWIRE / November 3, 2022 / Clairvoyant Therapeutics ("Clairvoyant"), a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased to anno... |